# Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

> **NCT04834557** · PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 90 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Digoxin 0.25 mg
- **DRUG:** Ursodeoxycholic acid (UDCA) 500 mg

## Key facts

- **NCT ID:** NCT04834557
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2022-05-18
- **Final completion:** 2022-09-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834557, "Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04834557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*